SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Maxim Group Initiates Nasus Pharma Coverage With Buy Rating

Maxim Group set a $7 price target for Nasus Pharma, implying 119.4% upside from the Oct. 29 close of $3.19.

NSRX

Related stories